SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
Status:
Recruiting
Trial end date:
2022-07-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of SCT-I10A plus standard
chemotherapy for Recurrent/ Metastatic Head and Neck Squamous cell Carcinoma